Literature DB >> 28295551

Hypopituitarism and hypothyroidism following atrioventricular block during nivolumab treatment.

Tomoko Oda1, Yu Sawada1, Etsuko Okada1, Takashi Yamaguchi1, Shun Ohmori1, Sanehito Haruyama1, Manabu Yoshioka1, Motonobu Nakamura1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28295551     DOI: 10.1111/1346-8138.13797

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  5 in total

1.  Thyrotoxicosis and Adrenocortical Hormone Deficiency During Immune-checkpoint Inhibitor Treatment for Malignant Melanoma.

Authors:  Hiroyuki Ariyasu; Hidefumi Inaba; Takayuki Ota; Hiroyuki Yamaoka; Yasushi Furukawa; Hiroshi Iwakura; Naotaka Doi; Yuki Yamamoto; Takashi Akamizu
Journal:  In Vivo       Date:  2018 Mar-Apr       Impact factor: 2.155

Review 2.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

3.  Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab.

Authors:  Wataru Omata; Satoko Nakamura; Chie Urasaki; Hiromichi Morita; Hiroki Funaishi; Kazuki Kobayashi; Hisashi Koide; Arata Tsutsumida; Hiroyuki Matsue
Journal:  Case Rep Dermatol       Date:  2022-03-21

Review 4.  Daily Lifestyle and Cutaneous Malignancies.

Authors:  Yu Sawada; Motonobu Nakamura
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

5.  Nivolumab Induced Thyroid Dysfunction: Unusual Clinical Presentation and Challenging Diagnosis.

Authors:  Carmine Iadarola; Laura Croce; Erica Quaquarini; Cristina Teragni; Sara Pinto; Antonio Bernardo; Rodolfo Fonte; Michele Marinò; Mario Rotondi; Luca Chiovato
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-17       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.